Skip to main content
BCAX filings

Corporate insider profile

Ivan Hyep Filing Activity

Latest reported as Chief Financial Officer of Bicara Therapeutics Inc. (BCAX).

Purchase filings
0
Reported companies
1
Net open-market value
-$399,497.12
Latest transaction
May 21, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
May 21, 2026Bicara Therapeutics Inc. (BCAX)Chief Financial OfficerSale9,200$20.42$187,883
Apr 21, 2026Bicara Therapeutics Inc. (BCAX)Chief Financial OfficerSale9,200$23.00$211,614